Jacqueline W Miller1, Laura-Mae Baldwin2, Barbara Matthews2, Katrina F Trivers3, C Holly Andrilla2, Denise Lishner2, Barbara A Goff4. 1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: JMiller5@cdc.gov. 2. Department of Family Medicine, University of Washington, Seattle, WA, USA. 3. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA. 4. Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Abstract
OBJECTIVE: To study physicians' beliefs about the effectiveness of different tests for cancer screening. METHODS: Data were examined from the Women's Health Survey of 1574 Family Medicine, Internal Medicine, and Obstetrics-Gynecology physicians to questions about their level of agreement about the clinical effectiveness of different tests for breast, cervical, ovarian, and colorectal cancer screening among average risk women. Data were weighted to the U.S. physician population based on the American Medical Association Masterfile. Multivariable logistic regression identified physician and practice characteristics significantly associated with physicians' beliefs. RESULTS: There were 1574 respondents, representing a 62% response rate. The majority of physicians agreed with the effectiveness of mammography for women aged 50-69years, Pap tests for women aged 21-65years, and colonoscopy for individuals aged ≥50years. A substantial proportion of physicians believed that non-recommended tests were effective for screening (e.g., 34.4% for breast MRI and 69.1% for annual pelvic exam). Physicians typically listed their respective specialty organizations as a top influential organization for screening recommendations. CONCLUSIONS: There were several substantial inconsistencies between physician beliefs in the effectiveness of cancer screening tests and the actual evidence of these tests' effectiveness which can lead both to underuse and overuse of cancer screening tests. Published by Elsevier Inc.
OBJECTIVE: To study physicians' beliefs about the effectiveness of different tests for cancer screening. METHODS: Data were examined from the Women's Health Survey of 1574 Family Medicine, Internal Medicine, and Obstetrics-Gynecology physicians to questions about their level of agreement about the clinical effectiveness of different tests for breast, cervical, ovarian, and colorectal cancer screening among average risk women. Data were weighted to the U.S. physician population based on the American Medical Association Masterfile. Multivariable logistic regression identified physician and practice characteristics significantly associated with physicians' beliefs. RESULTS: There were 1574 respondents, representing a 62% response rate. The majority of physicians agreed with the effectiveness of mammography for women aged 50-69years, Pap tests for women aged 21-65years, and colonoscopy for individuals aged ≥50years. A substantial proportion of physicians believed that non-recommended tests were effective for screening (e.g., 34.4% for breast MRI and 69.1% for annual pelvic exam). Physicians typically listed their respective specialty organizations as a top influential organization for screening recommendations. CONCLUSIONS: There were several substantial inconsistencies between physician beliefs in the effectiveness of cancer screening tests and the actual evidence of these tests' effectiveness which can lead both to underuse and overuse of cancer screening tests. Published by Elsevier Inc.
Entities:
Keywords:
Breast cancer; Cancer screening; Cervical cancer; Colorectal cancer; Ovarian cancer; Physician beliefs
Authors: Barbara A Goff; Jacqueline W Miller; Barbara Matthews; Katrina F Trivers; C Holly A Andrilla; Denise M Lishner; Laura-Mae Baldwin Journal: Obstet Gynecol Date: 2011-10 Impact factor: 7.661
Authors: Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Mona Shah; Otis W Brawley Journal: CA Cancer J Clin Date: 2011-01-04 Impact factor: 508.702
Authors: Paul K J Han; Carrie N Klabunde; Nancy Breen; Gigi Yuan; Alyssa Grauman; William W Davis; Stephen H Taplin Journal: Med Care Date: 2011-02 Impact factor: 2.983
Authors: Barbara A Goff; Barbara Matthews; C Holly A Andrilla; Jacqueline W Miller; Katrina F Trivers; Donna Berry; Denise M Lishner; Laura-Mae Baldwin Journal: Cancer Date: 2011-03-16 Impact factor: 6.860
Authors: Katrina F Trivers; Laura-Mae Baldwin; Jacqueline W Miller; Barbara Matthews; C Holly A Andrilla; Denise M Lishner; Barbara A Goff Journal: Cancer Date: 2011-07-25 Impact factor: 6.860
Authors: K Robin Yabroff; Jane Zapka; Carrie N Klabunde; Gigi Yuan; Dennis W Buckman; David Haggstrom; Steven B Clauser; Jacqueline Miller; Stephen H Taplin Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-10-05 Impact factor: 4.254
Authors: Emily McGinnis; Beth E Meyerson; Elissa Meites; Mona Saraiya; Rebecca Griesse; Emily Snoek; Laura Haderxhanaj; Lauri E Markowitz; William Smith Journal: Sex Transm Dis Date: 2017-10 Impact factor: 2.830
Authors: Archana Radhakrishnan; Sarah A Nowak; Andrew M Parker; Kala Visvanathan; Craig E Pollack Journal: Prev Med Date: 2017-11-17 Impact factor: 4.018
Authors: Courtney Macdonald; Danielle Mazza; Martha Hickey; Morgan Hunter; Louise A Keogh; kConFab Investigators; Sandra C Jones; Christobel Saunders; Stephanie Nesci; Roger L Milne; Sue-Anne McLachlan; John L Hopper; Michael L Friedlander; Jon Emery; Kelly-Anne Phillips Journal: JNCI Cancer Spectr Date: 2020-12-08